| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.03 | 0.5 |